Patients with Barrett's esophagus -- a condition caused by acid reflux -- may be vulnerable to coronavirus infection from what they swallow, according to a study published online in the journal Gastroenterology.
A new study examines the recovery of lung function and overall wellness in individuals who had varying degrees of COVID-19 severity.
Exactly how Montenegro, which has a population of 628,066 and close ties to Italy, has stayed coronavirus-free is not known.
According to Spectrum Solutions, the company’s saliva-based COVID-19 home test will be rolled out to the United Kingdom as part of the country’s efforts to test its entire population, weekly.
Read More
COVID-19 patients in the United Kingdom are now able to be treated with tocilizumab and sarilumab — drugs used to treat rheumatoid arthritis that recent studies showed can significantly reduce mortality risk and length of hospital stay up to 10 days.
Read More
A record 1.3 million travelers passed through US airports on Sunday, Jan 3 — the largest number since the beginning of the COVID-19 pandemic, according to the TSA.
Read More
Healthcare officials are weighing whether to delay the second doses of the COVID-19 vaccine or to halve the recommended dose in order to reach more people.
Read More
Roughly 20% more doses of Moderna’s COVID-19 vaccine will be produced in 2021, a minimum of 600 million.
Read More
A small number of recovering COVID-19 patients have exhibited severe psychotic symptoms and behavior, including delusions and acts of violence against others, the New York Times reports.
Read More
Colorado and California reported the first confirmed cases of the more infectious UK variant of COVID-19 on Wednesday in two men with no histories of travel.
Read More
Louisiana Congressman-elect Luke Letlow died of COVID-19 on Dec 29 at age 41. He is the first Congressional member or member-elect to die of the coronavirus.
Read More
One year ago, on Dec 30, 2019, the first media reports were published about a mysterious viral pneumonia spreading through Wuhan, China.
Read More
The Novavax vaccine is the fifth COVID-19 vaccine candidate to begin clinical trials, after Pfizer/BioNTech, Moderna, AstraZeneca, and Johnson & Johnson.
Read More
Researchers are investigating therapeutics that could potentially cut the amount of time a person with COVID-19 is infectious, which could reduce cases by the millions.
Read More
Patients with severe COVID-19 who develop ARDS have malfunctions in their immune systems that distinguish them from other COVID-19 patients.
Read More